Thomas J. Kipps, M.D., Ph.D., is Professor of Medicine and Head of Hematology/ Oncology at the University of California, San Diego's (UCSD) Department of Medicine. Dr. Kipps also serves as Deputy Director of Research Operations for the NCI-designated Comprehensive Cancer Center at UCSD. He graduated summa cum laude from Columbia University (Biochemistry), and magna cum laude from Harvard with an M.D. and a Ph.D. in immunology. After training in Internal Medicine, he completed fellowships in Hematology, Immunology, and Genetics at Stanford University.
Dr. Kipps served on the faculty at the Scripps Research Institute from 1985 to 1990, when he moved to UCSD. There he oversees a molecular and cellular immunology research laboratory and conducts translational research in immunology and genetics. He established investigator-initiated Phase I and II trials, including the first gene therapy trial in human leukemia, based on discoveries made in his laboratory. This involves the capacity of CD40-ligation to induce expression of immune co-stimulatory molecules that are critical for T cell activation, in response to presented tumor-associated antigen.
Dr. Kipps also leads the chronic lymphocytic leukemia (CLL) research consortium (CRC), a national consortium of basic and clinical investigators who are conducting research on adult leukemia. He has received numerous research awards, authored more than 210 peer-reviewed scientific articles and book chapters, and serves on several scientific journal editorial boards, the Progress Review Group, and other scientific advisory committees for public and private research funding and for industry.